CWM
WST icon

Centricity Wealth Management’s West Pharmaceutical WST Stock Holding History

Centricity Wealth Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$23.2K Hold
106
– – 0.02% 244
2025
Q1 		$23.7K Hold
106
– – 0.02% 236
2024
Q4 		$34.7K Buy
+106
New +$33.4K 0.03% 203

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

Centricity Wealth Management's WST Position: Q2 2025 in Review

Centricity Wealth Management held its West Pharmaceutical (WST) position steady in Q2 2025 at 106 shares worth $23.2K. The position accounts for 0.02% of the portfolio, ranked #244.

Centricity Wealth Management first reported a position in WST in Q4 2024 and has held it in 3 quarters since. The position peaked at $34.7K in Q4 2024. 730 funds tracked by Wall St. Rank hold WST as of Q2 2025.

  • Centricity Wealth Management held 106 shares of West Pharmaceutical worth $23.2K as of Q2 2025.
  • Centricity Wealth Management left its West Pharmaceutical share count unchanged in Q2 2025.
  • West Pharmaceutical made up 0.02% of Centricity Wealth Management's portfolio in Q2 2025, its #244 holding.
  • Centricity Wealth Management first reported a position in West Pharmaceutical in Q4 2024 and has held it in 3 quarters since.
  • Centricity Wealth Management's West Pharmaceutical position peaked at $34.7K in Q4 2024.
  • 730 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2025.

Based on Centricity Wealth Management's 13F filing for Q2 2025, filed 18 Jul 2025.